Annual report
4978.TEDINET S100OJYY
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 133
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥1.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥926m | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥647m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | −¥1.0bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | −¥507m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥789m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥892m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥627m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥935m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥574m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥812m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥575m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥813m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥601m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥2.2bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥575m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | −¥814m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥8.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥6.0bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥6.6bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.6bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥845m | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥656m | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥7.1bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.2bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.6bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.6bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥246m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥649m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥690m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥555m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥637m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥228m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥7m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-7.57 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-11.38 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.27 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.79 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-34.28 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥88.11 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥75.17 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥84.76 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥99.5 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥97.76 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 89.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.0% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.3% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.7% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.3% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 98 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 106 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 113 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 111 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 63 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥606m | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥429m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥492m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥405m | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥471m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥768m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | −¥382m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥559m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥564m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥191m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥292m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥540m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥996m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | −¥541m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | −¥997m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥905m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥213m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥3.6bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥6.1bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥6.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.7bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.4bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥641m | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥423m | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.7bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.5bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.4bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.2bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-7.13 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.96 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-12.71 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.12 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-56.87 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥91.73 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥79.12 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥91.69 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥104.28 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥96.78 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 92.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.1% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.1% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.9% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 82,270,891 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 71,667,391 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 71,406,891 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 71,066,391 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 63,912,891 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 31 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 34 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 34 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 30 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 21 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥1m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥15m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥7.3bn |
| Reconciling Itemsreconciling | segment ordinary income | 2021-04-01 → 2022-03-31 | −¥579m |
| Medical Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥20m |
| Medical Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥26m |
| Medical Businessreportable segment | employees | at 2022-03-31 | 7 pure |
| Medical Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥854m |
| Medical Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥854m |
| Medical Businessreportable segment | segment assets | at 2022-03-31 | ¥274m |
| Medical Businessreportable segment | segment ordinary income | 2021-04-01 → 2022-03-31 | −¥63m |
| Research Support Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥26m |
| Research Support Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥15m |
| Research Support Businessreportable segment | employees | at 2022-03-31 | 70 pure |
| Research Support Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Research Support Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Research Support Businessreportable segment | segment assets | at 2022-03-31 | ¥477m |
| Research Support Businessreportable segment | segment ordinary income | 2021-04-01 → 2022-03-31 | ¥135m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥47m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥42m |
| —segment total | employees | at 2022-03-31 | 77 pure |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥2.2bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥2.2bn |
| —segment total | segment assets | at 2022-03-31 | ¥750m |
| —segment total | segment ordinary income | 2021-04-01 → 2022-03-31 | ¥72m |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥24m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥5.3bn |
| Reconciling Itemsreconciling | segment ordinary income | 2020-04-01 → 2021-03-31 | −¥510m |
| Medical Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥37m |
| Medical Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥5m |
| Medical Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥86m |
| Medical Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥86m |
| Medical Businessreportable segment | segment assets | at 2021-03-31 | ¥284m |
| Medical Businessreportable segment | segment ordinary income | 2020-04-01 → 2021-03-31 | −¥372m |
| Research Support Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥25m |
| Research Support Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥30m |
| Research Support Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Research Support Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Research Support Businessreportable segment | segment assets | at 2021-03-31 | ¥446m |
| Research Support Businessreportable segment | segment ordinary income | 2020-04-01 → 2021-03-31 | ¥93m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥62m |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥35m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| —segment total | segment assets | at 2021-03-31 | ¥730m |
| —segment total | segment ordinary income | 2020-04-01 → 2021-03-31 | −¥278m |
| Medical Businessreportable segment | employees | at 2022-03-31 | 7 pure |
| Research Support Businessreportable segment | employees | at 2022-03-31 | 18 pure |
| —segment total | employees | at 2022-03-31 | 25 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,477
| Item | Context | Value | Unit |
|---|---|---|---|
| Gross profit | CurrentYearDuration | 803438000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 662029000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 535287000 | JPY |
| Other selling general and administrative expenses sga | Prior1YearDuration | 868718000 | JPY |
| Other selling general and administrative expenses sga | CurrentYearDuration | 915277000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 1530747000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 1450565000 | JPY |
| Operating income | Prior1YearDuration | -1048046000 | JPY |
| Operating income | CurrentYearDuration | -647127000 | JPY |
| Interest income noi | Prior1YearDuration | 3367000 | JPY |
| Interest income noi | CurrentYearDuration | 9182000 | JPY |
| Subsidy income noi | Prior1YearDuration | 176107000 | JPY |
| Subsidy income noi | CurrentYearDuration | 150943000 | JPY |
| Foreign exchange gains noi | Prior1YearDuration | 45769000 | JPY |
| Foreign exchange gains noi | CurrentYearDuration | 20680000 | JPY |
| Gain on investments in partnership noi | Prior1YearDuration | 39114000 | JPY |
| Gain on investments in partnership noi | CurrentYearDuration | － | JPY |
| Other noi | Prior1YearDuration | 45884000 | JPY |
| Other noi | CurrentYearDuration | 25184000 | JPY |
| Non operating income | Prior1YearDuration | 310244000 | JPY |
| Non operating income | CurrentYearDuration | 205991000 | JPY |
| Interest expenses noe | Prior1YearDuration | 319000 | JPY |
| Interest expenses noe | CurrentYearDuration | 342000 | JPY |
| Loss on investments in partnership noe | Prior1YearDuration | － | JPY |
| Loss on investments in partnership noe | CurrentYearDuration | 8921000 | JPY |
| Equity in losses of affiliates noe | Prior1YearDuration | 49640000 | JPY |
| Equity in losses of affiliates noe | CurrentYearDuration | 54379000 | JPY |
| Other noe | Prior1YearDuration | 968000 | JPY |
| Other noe | CurrentYearDuration | 2629000 | JPY |
| Non operating expenses | Prior1YearDuration | 50928000 | JPY |
| Non operating expenses | CurrentYearDuration | 66272000 | JPY |
| Ordinary income | Prior1YearDuration | -788730000 | JPY |
| Ordinary income | CurrentYearDuration | -507409000 | JPY |
| Impairment loss el | Prior1YearDuration | 23207000 | JPY |
| Impairment loss el | CurrentYearDuration | 66535000 | JPY |
| Extraordinary loss | Prior1YearDuration | 23207000 | JPY |
| Extraordinary loss | CurrentYearDuration | 66535000 | JPY |
| Income before income taxes | Prior1YearDuration | -811937000 | JPY |
| Income before income taxes | CurrentYearDuration | -573944000 | JPY |
| Income taxes current | Prior1YearDuration | 1614000 | JPY |
| Income taxes current | CurrentYearDuration | 1555000 | JPY |
| Income taxes deferred | Prior1YearDuration | 65000 | JPY |
| Income taxes deferred | CurrentYearDuration | -193000 | JPY |
| Income taxes | Prior1YearDuration | 1680000 | JPY |
| Income taxes | CurrentYearDuration | 1361000 | JPY |
| Profit loss | Prior1YearDuration | -813618000 | JPY |
| Profit loss | CurrentYearDuration | -575306000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YearDuration | -1045000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYearDuration | -211000 | JPY |
| Profit loss attributable to owners of parent | Prior1YearDuration | -812572000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |